1. 通訊作者. Ubenimex synergizes with the PD-L1 blockade in gastric cancer by competitively binding LAP3 with UBE3A. Cell Death Dis., 2025. (1區) 2. 并列通訊. The chromatin accessibility landscape of 2/3 partial hepatectomy in mice reveals hypoplastic hepatic progenitor cells. Commun Biol., 2025. (1區) 3. 并列通訊. Thymoquinone enhances efficacy of cervical cancer therapeutic vaccines via modulating CD8+ cells. Int Immunopharmacol., 2025. (2區) 4. 并列通訊. KGF inhibits TRIM21-mediated Keratin 10 protein stabilization in hypopharyngeal cancer. Cell Signal., 2025. (2區) 5. 并列通訊. VSIG4 induces the immunosuppressive microenvironment by promoting the infiltration of M2 macrophage and Tregs in clear cell renal cell carcinoma. Int Immunopharmacol., 2024. (2區) 6. 通訊作者. CXCL8 induces M2 macrophages polarization and inhibits CD8+ T cell infiltration to generate an immunosuppressive microenvironment in colorectal cancer. FASEB J, 2023. (2區) 7. 通訊作者. RNA demethylase ALKBH5 suppresses tumorigenesis via inhibiting proliferation and invasion and promoting CD8+ T cell infiltration in colorectal cancer. Translational Oncology, 2023. (2區) 8. 通訊作者. Siglec-15 as multifunctional molecule involved in osteoclast differentiation, cancer immunity, and microbial infection. Progress in Biophysics and Molecular Biology, 2023. (3區) 9. 通訊作者. IMB5036, a novel pyridazinone compound, inhibits hepatocellular carcinoma growth and metastasis. Investigational New Drugs, 2022. (3區) 10. 通訊作者. miR-148a-3p silences the CANX/MHC-I pathway and impairs CD8+ T cell-mediated immune attack in colorectal cancer. FASEB J, 2021. (2區) |
